ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY

ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY was reported 36 times

ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THIRD DEGREE CHEMICAL BURN OF SKIN 1 0.0238
1 PRODUCT DIFFICULT TO REMOVE 1 0.0167
2 ANTICOAGULATION DRUG LEVEL ABNORMAL 1 0.0067
3 ABSCESS SOFT TISSUE 1 0.0065
4 CERVIX HAEMORRHAGE UTERINE 1 0.0052
5 PRODUCT CONTAMINATION CHEMICAL 1 0.0046
6 HORMONE RECEPTOR POSITIVE BREAST CANCER 1 0.0037
7 ULTRASOUND SCAN ABNORMAL 1 0.0026
8 SOFT TISSUE SWELLING 1 0.0018
9 METAL POISONING 1 0.0017
10 PHARYNGEAL HYPOAESTHESIA 1 0.0011
11 APPLICATION SITE DERMATITIS 1 0.0011
12 BLOODY DISCHARGE 1 0.0009
13 DERMAL CYST 2 0.0008
14 AXILLARY PAIN 1 0.0007
15 BURNS SECOND DEGREE 1 0.0006
16 BREAST CYST 1 0.0006
17 SKIN INDURATION 1 0.0005
18 PURULENT DISCHARGE 2 0.0005
19 REACTION TO DRUG EXCIPIENTS 1 0.0005
20 CHEMICAL BURN OF SKIN 1 0.0004
21 SKIN DISCOMFORT 1 0.0004
22 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
23 MACULE 1 0.0004
24 SKIN WARM 2 0.0003
25 SKIN EROSION 1 0.0003
26 APPLICATION SITE RASH 4 0.0003
27 CERVIX CARCINOMA 1 0.0003
28 WOUND SECRETION 1 0.0003
29 SKIN ODOUR ABNORMAL 1 0.0003
30 FURUNCLE 2 0.0003
31 APPLICATION SITE EXFOLIATION 1 0.0002
32 SKIN SWELLING 2 0.0002
33 TONGUE DISCOLOURATION 1 0.0002
34 SUBCUTANEOUS ABSCESS 1 0.0002
35 APPLICATION SITE PAIN 4 0.0002
36 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
37 APPLICATION SITE IRRITATION 2 0.0002
38 APPLICATION SITE VESICLES 1 0.0002
39 PRODUCT FORMULATION ISSUE 1 0.0002
40 SKIN MASS 1 0.0001
41 METASTASES TO LYMPH NODES 1 0.0001
42 ABNORMAL FAECES 1 0.0001
43 SKIN HYPERPIGMENTATION 1 0.0001
44 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
45 BREAST CANCER STAGE I 1 0.0001
46 DEFORMITY 1 0.0001
47 RECALLED PRODUCT ADMINISTERED 1 0.0001
48 PRODUCT ODOUR ABNORMAL 1 0.0001
49 DERMATITIS CONTACT 1 0.0001
50 HAIR COLOUR CHANGES 1 0.0001
51 DERMATITIS ALLERGIC 1 0.0001
52 IMMUNE SYSTEM DISORDER 1 0.0001
53 GASTROENTERITIS 1 0.0001
54 SKIN HAEMORRHAGE 1 0.0001
55 HYPOAESTHESIA ORAL 1 0.0001
56 LACRIMATION INCREASED 2 0.0001
57 LYMPHOMA 1 0.0001
58 RASH ERYTHEMATOUS 3 0.0001
59 ABSCESS 1 0.0001
60 SCAR 1 0.0001
61 RASH MACULAR 2 0.0001
62 BACTERIAL INFECTION 1 0.0001
63 DERMATITIS 1 0.0000
64 APPLICATION SITE PRURITUS 1 0.0000
65 SKIN IRRITATION 2 0.0000
66 MUSCLE TWITCHING 1 0.0000
67 MENTAL IMPAIRMENT 1 0.0000
68 RASH GENERALISED 1 0.0000
69 APPLICATION SITE ERYTHEMA 1 0.0000
70 PAIN OF SKIN 1 0.0000
71 SKIN LESION 1 0.0000
72 SWOLLEN TONGUE 1 0.0000
73 RHINORRHOEA 2 0.0000
74 STAPHYLOCOCCAL INFECTION 1 0.0000
75 EXPIRED PRODUCT ADMINISTERED 1 0.0000
76 SKIN BURNING SENSATION 2 0.0000
77 DYSARTHRIA 1 0.0000
78 THERAPY NON-RESPONDER 1 0.0000
79 SKIN DISCOLOURATION 1 0.0000
80 HYPERSENSITIVITY 4 0.0000
81 OCULAR HYPERAEMIA 1 0.0000
82 CELLULITIS 1 0.0000
83 ERYTHEMA 4 0.0000
84 NERVOUSNESS 1 0.0000
85 RASH 8 0.0000
86 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
87 ANAPHYLACTIC REACTION 1 0.0000
88 BLISTER 1 0.0000
89 EYE PAIN 1 0.0000
90 BURNING SENSATION 1 0.0000
91 DYSGEUSIA 1 0.0000
92 ACNE 1 0.0000
93 CHRONIC KIDNEY DISEASE 1 0.0000
94 SKIN EXFOLIATION 1 0.0000
95 TACHYCARDIA 1 0.0000
96 SWELLING 1 0.0000
97 PRURITUS 4 0.0000
98 ASTHMA 1 0.0000
99 SEIZURE 1 0.0000
100 CHILLS 1 0.0000
101 HYPERHIDROSIS 1 0.0000
102 RENAL FAILURE 1 0.0000
103 DEHYDRATION 1 0.0000
104 PRODUCT QUALITY ISSUE 1 0.0000
105 MEMORY IMPAIRMENT 1 0.0000
106 DYSPNOEA 4 0.0000
107 INFECTION 1 0.0000
108 BLOOD PRESSURE INCREASED 1 0.0000
109 HEADACHE 4 0.0000
110 URTICARIA 1 0.0000
111 CEREBROVASCULAR ACCIDENT 1 0.0000
112 CHEST PAIN 1 0.0000
113 PRODUCT USE ISSUE 1 0.0000
114 ASTHENIA 2 0.0000
115 ALOPECIA 1 0.0000
116 SOMNOLENCE 1 0.0000
117 FEELING ABNORMAL 1 0.0000
118 WEIGHT DECREASED 1 0.0000
119 COUGH 1 0.0000
120 CONDITION AGGRAVATED 1 0.0000
121 PAIN 2 0.0000
122 PNEUMONIA 1 0.0000
123 PYREXIA 1 0.0000
124 FATIGUE 1 0.0000
125 NAUSEA 1 0.0000
126 OFF LABEL USE 1 0.0000
127 DRUG INEFFECTIVE 1 0.0000